Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03447652 · ClinicalTrials.gov registry record · NA

A Study Investigating The Effects Of An Ankle Rehabilitation Program On High School Athletes With Ankle Instability

A NA study, sponsored by Georgia State University.

Completed
Registry status
NA
Development phase
43
Enrollment target

NCT03447652: Completed NA study, sponsored by Georgia State University.

NCT03447652 is a NA study that has completed, run by Georgia State University. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03447652, a NA study, has completed, sponsored by Georgia State University.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target

Study Summary

A randomized controlled trial investigating the effects of a 4-week ankle rehabilitation program on high school athletes with chronic ankle instability.

Primary Outcome

Static Balance Clinical Tests

Interventions

  • OTHER Resistance Band Ankle Rehabilitation
  • OTHER Biomechanical Ankle Platform System Rehabilitation
  • OTHER Combination Rehabilitation

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2017-08-14
Est. Completion 2018-08-30
Phase NA
Georgia State University

45 total trials

What the finished NCT03447652 record still lists

NCT03447652 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 3 interventions - of which Resistance Band Ankle Rehabilitation is the first listed.

NCT03447652 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03447652 about?

NCT03447652 is a clinical study titled "A Study Investigating The Effects Of An Ankle Rehabilitation Program On High School Athletes With Ankle Instability". A randomized controlled trial investigating the effects of a 4-week ankle rehabilitation program on high school athletes with chronic ankle instability.

What is the current status of trial NCT03447652?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2017-08-14. Estimated completion is 2018-08-30.

What interventions are being tested in trial NCT03447652?

The interventions under investigation include: Resistance Band Ankle Rehabilitation (OTHER), Biomechanical Ankle Platform System Rehabilitation (OTHER), Combination Rehabilitation (OTHER).

Who is sponsoring clinical trial NCT03447652?

This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03447652's enrollment target sits among peer trials

43 1435th of 2000 higher than 565 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03726359 · 43 participants · Phase 1

    Phase I Study of Fractionated Stereotactic Radiation Therapy

  • NCT03850418 · 43 participants · Phase 2

    Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

  • NCT04144023 · 43 participants · Phase 1

    A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

  • NCT04176718 · 43 participants · Phase 2

    Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03447652, the US trial registry maintained by the National Library of Medicine. NCT03447652 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.